Rheumatologists and primary care physicians will find the "Rheumatoid Arthritis Virtual Grand Rounds" to be extremely beneficial. Hosted by experts in the field, 17 patient cases will help improve the quality of care provided through patient case studies and provide new information about the available treatments for rheumatoid arthritis.
Rheumatologists and primary care physicians will find the “Rheumatoid Arthritis Virtual Grand Rounds,” brought to you by the Cleveland Clinic, to be extremely beneficial. Hosted by experts in the field, the 17 patient cases already archived and are still available for CME credit, will help improve the quality of care provided through patient case studies and provide new information about the available treatments for rheumatoid arthritis (RA).
Healthcare professionals who participate in the courses will be able to “compare and contrast biologic therapies with regard to clinical outcomes and adverse effects in patients with RA,” discuss treatments for patients with RA and comorbid conditions, explain “current evidence-based treatment using biologic therapies in RA,” and “recognize the broad implications of clinical studies over the past 10 years for clinical practice for patients with RA.”
Here are some examples of the types of courses that are available in this educational series:
Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
Expiration Date: October 30, 2010
Upon completing this activity, healthcare professionals will be able to discuss the risk of comorbidity, recognize risk factors for patients to develop osteoporosis and cardiovascular disease, and evaluate the risks and benefits of available rheumatoid arthritis treatments that are related to osteoporosis and CVD.
The Application of New ACR Recommendations in the Management of Rheumatoid Arthritis: A Case Study Approach
Expiration Date: March 30, 2010
Healthcare professionals who treat rheumatoid arthritis should take this course as it focuses on initial and long-term strategies for patients with “early RA in the context of the ACR Treatment Recommendations.” Featured topics include nonbiologic and biologic therapies for RA, patient management strategies, and treatment approaches based on evidence-based treatment recommendations.
Managing Rheumatoid Arthritis Patients with an Inadequate Response to TNF Inhibitors
Expiration Date: May 14, 2010
Rheumatologists and primary care physicians who participate in this course will review the treatment options that are available to a patient with rheumatoid arthritis “who has had a lack of response to one or more biologic disease-modifying antirheumatic drugs.”